These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 2192850)

  • 1. Combination insulin-sulfonylurea therapy.
    Lebovitz HE; Pasmantier R
    Diabetes Care; 1990 Jun; 13(6):667-75. PubMed ID: 2192850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined insulin-sulfonylurea therapy in treatment of NIDDM.
    Groop LC; Groop PH; Stenman S
    Diabetes Care; 1990 Aug; 13 Suppl 3():47-52. PubMed ID: 2209344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
    Johnson JL; Wolf SL; Kabadi UM
    Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin: either alone or combined with oral hypoglycemic agents.
    Firth RG
    Prim Care; 1988 Sep; 15(3):665-83. PubMed ID: 3054969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfonylureas in NIDDM.
    Groop LC
    Diabetes Care; 1992 Jun; 15(6):737-54. PubMed ID: 1600834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of metformin in the treatment of type 2 diabetes mellitus.
    Davidson MB; Peters AL
    Am J Med; 1997 Jan; 102(1):99-110. PubMed ID: 9209206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type II diabetic subjects with secondary failure: treatment with prebreakfast mixed ultralente and regular insulin with a sulfonylurea.
    Kabadi UM; Kabadi MU
    J Fam Pract; 1991 Oct; 33(4):349-53. PubMed ID: 1919450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gliclazide and bedtime insulin are more efficient than insulin alone for type 2 diabetic patients with sulfonylurea secondary failure.
    Chazan AC; Gomes MB
    Braz J Med Biol Res; 2001 Jan; 34(1):49-56. PubMed ID: 11151028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A metaanalysis.
    Pugh JA; Wagner ML; Sawyer J; Ramirez G; Tuley M; Friedberg SJ
    Diabetes Care; 1992 Aug; 15(8):953-9. PubMed ID: 1387073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined therapy with a sulfonylurea plus evening insulin: safe, reliable, and becoming routine.
    Riddle MC
    Horm Metab Res; 1996 Sep; 28(9):430-3. PubMed ID: 8911978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy with insulin and sulfonylureas for type II diabetes.
    Bailey TS; Mezitis NH
    Diabetes Care; 1990 Jun; 13(6):687-95. PubMed ID: 2192852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of sulfonylureas with insulin in type 2 diabetes mellitus.
    Kabadi MU; Kabadi UM
    Ann Pharmacother; 2003 Nov; 37(11):1572-6. PubMed ID: 14565810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination use of sulfonylureas and insulin in the treatment of noninsulin-dependent diabetes mellitus.
    Montgomery PA
    Pharmacotherapy; 1992; 12(4):292-9. PubMed ID: 1518728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin versus insulin plus sulfonylureas in type 2 diabetic patients with secondary failure to sulfonylureas.
    Scheen AJ; Lefèbvre PJ
    Diabetes Res Clin Pract; 1989 May; 6(4):S33-42; discussion S42-3. PubMed ID: 2666061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral hypoglycemic agents in type II diabetes mellitus.
    Lubbos H; Miller JL; Rose LI
    Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined insulin and sulfonylurea treatment in diabetes mellitus].
    Ravina A; Minuhin O
    Harefuah; 1986 Jan; 110(1):11-4. PubMed ID: 3514394
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment strategies for secondary sulfonylurea failure. Should we start insulin or add metformin? Is there a place for intermittent insulin therapy?
    Groop L; Widén E
    Diabete Metab; 1991 May; 17(1 Pt 2):218-23. PubMed ID: 1936480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combined treatment with insulin and sulfonylurea in non-insulin-dependent diabetic patients with secondary failure. Rationale and guidelines.
    Tiengo A; Del Prato S
    Diabetes Res Clin Pract; 1988; 4 Suppl 1():75-81. PubMed ID: 3042339
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of non-insulin-dependent diabetes mellitus with metformin.
    Guthrie R
    J Am Board Fam Pract; 1997; 10(3):213-21. PubMed ID: 9159660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus.
    Vannasaeng S; Ploybutr S; Nitiyanant W; Peerapatdit T; Vichayanrat A
    J Med Assoc Thai; 1995 Nov; 78(11):578-85. PubMed ID: 8576667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.